Skip to main content
DA / EN

Faecal microbiota transplantation (FMT)

Faecal microbiota transplantation products are manufactured at the Dept. of Clinical Immunology, OUH, and distributed to clinical departments at all hospitals in the Region of Southern Denmark. These products are used on a daily basis in the routine treatment of patients with recurrent Clostridioides difficile infections (CDI). The research on FMT includes the assessment and optimization of its clinical application in patients with CDI and the investigation into its clinical value in other conditions with a focus on immune-mediated diseases including arthritis and inflammatory bowel disease. We collaborate with clinical departments in the Region of Southern Denmark and with both local, national and international laboratories to evaluate the content of the FMT product and the mode-of-action of FMT using both immunological assays, culturomics, metagenomics, and metabolomics.

 

Members of the team

Maja Skov Kragsnæs, MD, Ph.D.

Dorte Kinggaard Holm, MSc, Ph.D.

Anne Christine Nilsson, MD

Jens Kjeldsen, MD, Ph.D .

Torkell Ellingsen, MD, Ph.D.

Ulrik Stenz Justesen, MD, DMSc.

Katrine Agerbo Hovmand, medical student

Frederik Cold, MD, Ph.D.

Emil Ainsworth Jochumsen, MD

Kristina Fruerlund Rasmussen, MD

Collaborators from clinical departments


Ongoing projects

FRONT trial – a 52-week superiority RCT evaluating safety and efficacy of multiple capsule FMTs in immune-mediated arthritis and inflammatory bowel disease. Principal investigators: Maja Skov Kragsnæs and Torkell Ellingsen.

FLORA trial – exploration of clinical predictors and effect-modifiers of FMT in patients with moderate to severe psoriatic arthritis. Principal investigators: Maja Skov Kragsnæs and Torkell Ellingsen.

FMT-AUD – a 12-week superiority RCT evaluating safety and efficacy of one FMT in patients with uncomplicated diverticulitis. Principal investigators: Camilla Thorndahl Nielsen and Thomas Bjørsum-Meyer.

FMT culturomics – Impact of storage conditions on live bacteria in faecal microbiota transplantation products using culturomics. Principal investigators: Katrine Agerbo Hovmand, Ulrik Stenz Justesen, and Maja Skov Kragsnæs.

 

Project options for students

Students are very welcome to contact Maja Skov Kragsnaes (maja.skov.kragsnaes@rsyd.dk), Torkell Ellingsen (torkell.ellingsen@rsyd.dk), or Dorte Kinggaard Holm (dorte.holm@rsyd.dk) for more information on pre-graduate project options.

 

List of publications

Safety and efficacy of faecal microbiota transplantation in patients with acute uncomplicated diverticulitis: study protocol for a randomised placebo-controlled trial. Thorndal C, Kragsnaes MS, Nilsson AC, et al.  Therapeutic Advances in Gastroenterology 2025;18.

Does This Fecal Microbiota Transplant Work? Quality assurance of capsule based Fecal Microbiota Transplant production. Jochumsen EA, Kragsnaes MS, Nilsson AC, et al.  Scandinavian Journal of Gastroenterology Oct 1, 2024.

Dynamics of inflammation-associated plasma proteins following faecal microbiota transplantation in patients with psoriatic arthritis and healthy controls: exploratory findings from the FLORA trial. Kragsnaes MS, Jensen JRB, Nilsson AC, et alRMD Open2024;10:e003750.  

Small intestinal permeability and metabolomic profiles in feces and plasma associate with clinical response in patients with active psoriatic arthritis participating in a fecal microbiota transplantation trial: exploratory findings from the FLORA trial. Kragsnaes MS, Blanco JM, Mullish BH, et al.  ACR Open Rheumatol. 2023;10.1002

Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic arthritis: an exploratory randomised placebo-controlled trial. Kragsnaes MS, Kjeldsen J, HornHC, et alAnn Rheum Dis. 20212021 Sep;80(9):1158-1167.

Experiences and perceptions of patients with psoriatic arthritis participating in a trial of faecal microbiota transplantation: a nested qualitative study. Kragsnaes MS, Sødergren ST, Kjeldsen J, et al.  BMJ Open. 2021;11(3):e039471 

How do I Establish a Stool Bank for Fecal Microbiota Transplantation within the Blood- and Tissue Transplant Service? Kragsnaes MS, Nilsson AC, Kjeldsen J, et alTransfusion 2020;60:1135-41

Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised placebo-controlled trial. Kragsnaes MS, Kjeldsen J, Horn HC, et al. . BMJ Open. 2018;8:e019231. 

Last Updated 18.03.2025